Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Allergy Clin Immunol. 2002 Dec;110(6 Suppl):S229-35.

Novel beta2-adrenergic receptor signaling pathways.

Author information

  • Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA. jeff.benovic@mail.tju.edu

Abstract

The beta(2)-adrenergic receptor (beta(2)AR) is perhaps the most thoroughly investigated of all G-protein-coupled receptors. Although the classical pathway of beta(2)AR signaling involves agonist-promoted binding of the receptor to the heterotrimeric guanosine triphosphate-binding protein G(s), activation of adenylyl cyclase, and production of cyclic adenosine monophosphate (cAMP), current evidence suggests that beta(2)AR signaling is regulated by interaction with multiple proteins. These interactions fall into 3 major groups: guanosine triphosphate-binding proteins such as G(s) and G(i); protein kinases such as the cAMP-dependent protein kinase, protein kinase C, G-protein-coupled receptor kinases, and tyrosine kinases; and adaptor proteins such as arrestins, A-kinase anchoring proteins, and the Na(+)/H(+)-exchanger regulatory factor. This review discusses these various interactions with particular emphasis on their role in regulating beta(2)AR signaling and trafficking.

PMID:
12464929
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk